AVTX · Avalo Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Avalo Therapeutics Inc Is A Clinical Stage Biotechnology Company Fully Dedicated To Developing Il-1b-Based Treatments For Immune-Mediated Inflammatory Diseases. The Company'S Asset Is Abdakibart (Avtx-009) An Anti-Il-1b Monoclonal Antibody ("Mab"), Targeting Inflammatory Diseases. Avalos Pipeline Also Includes Quisovalimab (Anti-Light Mab) And Avtx-008 (Btla Agonist Fusion Protein), Avtx-006 And Avtx-913.

HealthcareNasdaqUSMid Float

FLOAT

48.6M

FREE FLOAT %

91%

SHARES O/S

53.6M

MARKET CAP

$371.7M

EXCHANGE

Nasdaq

COUNTRY

AVTX Catalyst History

No catalysts recorded for AVTX yet

Day Trader Sniper hasn't classified a publishable catalyst for AVTX yet. New events appear here as they're scored.

Be early on the next AVTX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

AVTX · Avalo Therapeutics, Inc.

AVTX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.